-
-
-
-
-
-
-
Amylyx Pharmaceuticals (AMLX) Confirms Stock Trading Halted Today Ahead of FDA Meeting
-
-
-
-
-
-
-
Amylyx (AMLX) Climbs 15% After Announces FDA Plan to Reconvene Advisory Committee to Review AMX0035 NDA for the Treatment of ALS on September 7
-
-
-
-
-
-
-
UPDATE: Goldman Sachs Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
-
-
-
-
-
-
-
Amylyx Pharmaceuticals Announces FDA Advisory Committee Meeting to Review New Drug Application for AMX0035 for the Treatment of ALS Scheduled for March 30, 2022
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

